Esperion Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Great. Good afternoon, everyone. My name is Jess Fye. I'm a biotech analyst at JPMorgan, and we are delighted to be continuing the conference today with Esperion. We're not going to switch rooms for Q&A. Instead, if you have a question after the presentation, you can raise your hand, so one will bring you a microphone or you can submit your questions electronically as well.
So with that out of the way, let me turn it over to Esperion CEO, Sheldon Koenig, for the presentation.
Good afternoon, everybody. Thank you. On behalf of Esperion, the company, all the employees, we're very happy to be here. Thank you to JPMorgan as well for allowing us to be here and share with you what's been really an exciting couple of months and a really exciting couple of days, and we're happy here to share that excitement with you. I have a countdown timer on my phone, although I don't have my phone on me because I can
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |